Setting a research agenda for progressive multiple sclerosis: the International Collaborative on Progressive MS. (Q36613404)

international cooperation

14 November 2020

1 reference

1 reference

Alan Thompson

2

0 references

Giancarlo Comi

10

object named as

Giancarlo Comi

1 reference

15 August 2017

Robert J Fox

1

1 reference

15 August 2017

David Baker

3

1 reference

15 August 2017

Peer Baneke

4

1 reference

15 August 2017

Doug Brown

5

1 reference

15 August 2017

Paul Browne

6

1 reference

15 August 2017

Dhia Chandraratna

7

1 reference

15 August 2017

Olga Ciccarelli

8

1 reference

15 August 2017

Timothy Coetzee

9

1 reference

15 August 2017

Anthony Feinstein

11

1 reference

15 August 2017

Raj Kapoor

12

1 reference

15 August 2017

Karen Lee

13

1 reference

15 August 2017

Marco Salvetti

14

1 reference

15 August 2017

Kersten Sharrock

15

1 reference

15 August 2017

Ahmed Toosy

16

1 reference

15 August 2017

Paola Zaratin

17

1 reference

15 August 2017

Kim Zuidwijk

Multiple Sclerosis Journal

18

1 reference

15 August 2017

language of work or name

1 reference

23 August 2012

1 reference

15 August 2017

1 November 2012

10 references

25 April 2019

20 June 2019

22 June 2019

30 June 2019

25 June 2019

19 September 2019

27 August 2020

28 August 2020

8 September 2020

14 November 2020

11 references

15 August 2017

25 April 2019

20 June 2019

22 June 2019

30 June 2019

25 June 2019

19 September 2019

27 August 2020

28 August 2020

8 September 2020

14 November 2020

18

1 reference

15 August 2017

1534-1540

1 reference

15 August 2017

11

1 reference

15 August 2017

Creative Commons Attribution 2.5 Generic

10 references

25 April 2019

20 June 2019

22 June 2019

30 June 2019

25 June 2019

19 September 2019

27 August 2020

28 August 2020

8 September 2020

14 November 2020

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Experimental in vivo and in vitro models of multiple sclerosis: EAE and beyond

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Energy failure in multiple sclerosis and its investigation using MR techniques

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

CytoSolve: A Scalable Computational Method for Dynamic Integration of Multiple Molecular Pathway Models

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Chronic progressive multiple sclerosis - pathogenesis of neurodegeneration and therapeutic strategies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Point-and-click cursor control with an intracortical neural interface system by humans with tetraplegia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Towards molecular imaging of multiple sclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Quality of life in multiple sclerosis: determinants, measurement, and use in clinical practice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

The relevance of animal models in multiple sclerosis research

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Evidence for polygenic susceptibility to multiple sclerosis--the shape of things to come

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Models of autoimmune demyelination in the central nervous system: on the way to translational medicine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Predicting new molecular targets for known drugs

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Imaging outcomes for neuroprotection and repair in multiple sclerosis trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Drug target identification using side-effect similarity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Risk alleles for multiple sclerosis identified by a genomewide study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Relation between functional brain imaging, cognitive impairment and cognitive rehabilitation in patients with multiple sclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Functional brain reorganization in multiple sclerosis: evidence from fMRI studies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Defining the clinical course of multiple sclerosis: Results of an international survey

30 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

30 September 2017

https://api.crossref.org/works/10.1177%2F1352458512458169

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Measuring myelin repair and axonal loss with diffusion tensor imaging.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Anxiety disorders and their clinical correlates in multiple sclerosis patients.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573679

A novel adaptive design strategy increases the efficiency of clinical trials in secondary progressive multiple sclerosis

20 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1177%2F1352458512458169

Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1177%2F1352458512458169

Training-dependent plasticity in patients with multiple sclerosis

21 January 2018

1 reference

12 December 2020

CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis

1 reference

12 December 2020

Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis

1 reference

12 December 2020

Nonprofit disease groups earmark grants for drug repositioning

1 reference

12 December 2020

Experimental models of multiple sclerosis

1 reference

12 December 2020